炎症性肠病患者消化系统癌症发病率与死亡率的基于人群匹配队列研究
该研究利用加拿大安大略省1994-2020年行政与癌症登记数据,将110,919例炎症性肠病患者与1,109,190名匹配对照比较消化系统癌症发病率趋势及风险比。结果显示结直肠癌发病率在溃疡性结肠炎患者与对照中均下降,而小肠癌、肝外消化系统癌症尤其是肝癌和胆管癌在患者中上升更快;2010年后患者结直肠癌、小肠癌、胆管癌和胰腺癌发病率及死亡率仍高于对照。
要点
- 溃疡性结肠炎患者结直肠癌发病率年均下降1.81%,对照下降2.79%。
- 克罗恩病患者小肠癌发病率年均上升9.68%,高于对照的3.64%。
- 2010年后患者结直肠癌、小肠癌、胆管癌和胰腺癌发病率及死亡率仍高于对照。
核心结论
- 炎症性肠病患者结直肠癌发病率下降,其他消化系统癌症发病率上升;结直肠癌、小肠癌、胆管癌和胰腺癌的发病率及死亡率仍高于对照。
研究设计与样本
- 基于加拿大安大略省1994-2020年行政与癌症登记数据的基于人群匹配队列研究,纳入110,919例炎症性肠病患者与1,109,190名按性别和出生年1:10匹配的对照。
主要发现
- 溃疡性结肠炎患者结直肠癌发病率年均变化百分比为-1.81(95%CI -2.48至-1.156),对照为-2.79(95%CI -3.44至-2.14)。
- 克罗恩病患者小肠癌发病率年均变化百分比为9.68(95%CI 2.51-17.3),高于对照的3.64(95%CI 1.52-5.80)。
- 炎症性肠病患者肝外消化系统癌症发病率年均变化百分比为3.27(95%CI 1.83-4.73),对照为-1.87(95%CI -2.33至-1.42)。
- 炎症性肠病患者肝癌发病率年均变化百分比为8.48(95%CI 4.11-13.1),胆管癌为7.22(95%CI 3.74-10.8)。
- 2010年后,炎症性肠病患者结直肠癌(1.60;95%CI 1.46-1.75)、小肠癌(4.10;95%CI 3.37-4.99)、胆管癌(2.33;95%CI 1.96-2.77)和胰腺癌(1.19;95%CI 1.00-1.40)的发病率及相应死亡率高于对照。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: To study digestive system cancer risks in individuals with inflammatory bowel diseases (IBDs) in the biologic era. METHODS: We used population-level administrative and cancer registry data from Ontario, Canada, (1994-2020) to compare people with IBD to matched controls (1:10 by sex and birth year) on trends in age-sex standardized cancer incidence and risk ratios of incident cancers and cancer-related deaths. RESULTS: Among 110,919 people with IBD and 1,109,190 controls, colorectal cancer incidence (per 100,000 person-years) declined similarly in people with ulcerative colitis (average annual percentage change [AAPC] -1.81; 95% confidence interval [CI] -2.48 to -1.156) and controls (AAPC -2.79; 95% CI -3.44 to -2.14), while small bowel cancer incidence rose faster in those with Crohn's disease (AAPC 9.68; 95% CI 2.51-17.3) than controls (AAPC 3.64; 95% CI 1.52-5.80). Extraintestinal digestive cancer incidence rose faster in people with IBD (AAPC 3.27; 95% CI 1.83-4.73) than controls (AAPC -1.87; 95% CI -2.33 to -1.42), particularly for liver (IBD AAPC 8.48; 95% CI 4.11-13.1) and bile duct (IBD AAPC 7.22; 95% CI 3.74-10.8) cancers. Beyond 2010, the incidences (and respective mortality rates) of colorectal (1.60; 95% CI 1.46-1.75), small bowel (4.10; 95% CI 3.37-4.99), bile duct (2.33; 95% CI 1.96-2.77), and pancreatic (1.19; 95% CI 1.00-1.40) cancers were higher in people with IBD. DISCUSSION: Cancer incidence is declining for colorectal cancer and rising for other digestive cancers in people with IBD. Incidence and mortality remain higher in people with IBD than controls for colorectal, small bowel, bile duct, and pancreatic cancers.
引用
- Murthy SK, Tandon P, Matthews P, et al. A Population-Based Matched Cohort Study of Digestive System Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease. Am J Gastroenterol. 2024. PMID: 38916226. doi:10.14309/ajg.0000000000002900
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。